These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2040432)

  • 41. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus.
    Lee PK; Kreiswirth BN; Deringer JR; Projan SJ; Eisner W; Smith BL; Carlson E; Novick RP; Schlievert PM
    J Infect Dis; 1992 Jun; 165(6):1056-63. PubMed ID: 1583323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal violet binding, cell surface properties and extracellular enzyme profiles of Staphylococcus aureus producing toxic shock syndrome toxin-1.
    Naidu AS; Jimenez J; Rollof J; Aleljung P; Nilsson-Ehle P; Larsson L; Hedström SA
    Zentralbl Bakteriol; 1989 May; 271(1):11-21. PubMed ID: 2669786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toxic shock syndrome: A dermatological emergency.
    Swarbrick AW; Kumarasinghe SP
    Australas J Dermatol; 2018 May; 59(2):154-155. PubMed ID: 28960233
    [No Abstract]   [Full Text] [Related]  

  • 44. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1.
    Schaefers MM; Breshears LM; Anderson MJ; Lin YC; Grill AE; Panyam J; Southern PJ; Schlievert PM; Peterson ML
    PLoS One; 2012; 7(3):e32813. PubMed ID: 22431984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of toxic shock syndrome toxin-1 production in Staphylococcus aureus strains isolated in Denmark between 1959 and 1990.
    Ejlertsen T; Jensen A; Lester A; Rosdahl VT
    Scand J Infect Dis; 1994; 26(5):599-604. PubMed ID: 7855557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of strain of Staphylococcus aureus on synergism with Candida albicans resulting in mouse mortality and morbidity.
    Carlson E
    Infect Immun; 1983 Oct; 42(1):285-92. PubMed ID: 6352497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toxic shock syndrome--the role of the toxin.
    Bergdoll MS; Reiser RF; Crass BA; Robbins RN; Thompson NE
    Postgrad Med J; 1985; 61 Suppl 1():35-8. PubMed ID: 3932991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody.
    Best GK; Scott DF; Kling JM; Thompson MR; Adinolfi LE; Bonventre PF
    Infect Immun; 1988 Apr; 56(4):998-9. PubMed ID: 3346079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Production of a toxic shock syndrome toxin variant by Staphylococcus aureus strains associated with sheep, goats, and cows.
    Ho G; Campbell WH; Bergdoll MS; Carlson E
    J Clin Microbiol; 1989 Sep; 27(9):1946-8. PubMed ID: 2778060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toxic shock syndrome associated with TSST-1 producing coagulase-negative staphylococci.
    Kahler RC; Boyce JM; Bergdoll MS; Lockwood WR; Taylor MR
    Am J Med Sci; 1986 Nov; 292(5):310-2. PubMed ID: 3777014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxic shock syndrome in a horse with Staphylococcus aureus pneumonia.
    Holbrook TC; Munday JS; Brown CA; Glover B; Schlievert PM; Sanchez S
    J Am Vet Med Assoc; 2003 Mar; 222(5):620-3, 601-2. PubMed ID: 12619842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genotyping of Staphylococcus aureus in bovine mastitis and correlation to phenotypic characteristics.
    Artursson K; Söderlund R; Liu L; Monecke S; Schelin J
    Vet Microbiol; 2016 Sep; 193():156-61. PubMed ID: 27599942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.
    de Azavedo JC; Arbuthnott JP
    Infect Immun; 1984 Nov; 46(2):314-7. PubMed ID: 6500691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.
    Lin YC; Anderson MJ; Kohler PL; Strandberg KL; Olson ME; Horswill AR; Schlievert PM; Peterson ML
    Biochemistry; 2011 Aug; 50(33):7157-67. PubMed ID: 21749039
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localization of biologically important regions on toxic shock syndrome toxin 1.
    Murray DL; Earhart CA; Mitchell DT; Ohlendorf DH; Novick RP; Schlievert PM
    Infect Immun; 1996 Jan; 64(1):371-4. PubMed ID: 8557369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.
    Li J; Wang W; Xu SX; Magarvey NA; McCormick JK
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3360-5. PubMed ID: 21282650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of various animal species to experimental infection with different strains of Staphylococcus aureus.
    Kohrman KA; Kirkland JJ; Danneman PJ
    Rev Infect Dis; 1989; 11 Suppl 1():S231-6; discussion S236-7. PubMed ID: 2928641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
    Bonventre PF; Heeg H; Edwards CK; Cullen CM
    Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.
    Hu DL; Omoe K; Sasaki S; Sashinami H; Sakuraba H; Yokomizo Y; Shinagawa K; Nakane A
    J Infect Dis; 2003 Sep; 188(5):743-52. PubMed ID: 12934191
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Staphylococcus aureus of phage type 187 isolated from people occurred to be a genes carrier of eneterotoxin C and toxic shock syndrome toxin-1 (TSST-1).
    Piechowicz L; Garbacz K; Galiński J
    Int J Hyg Environ Health; 2008 Jul; 211(3-4):273-82. PubMed ID: 17997135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.